Cathy Eng

Cathy Eng

UNVERIFIED PROFILE

Are you Cathy Eng?   Register this Author

Register author
Cathy Eng

Cathy Eng

Publications by authors named "Cathy Eng"

Are you Cathy Eng?   Register this Author

100Publications

2340Reads

42Profile Views

Minocycline for Symptom Reduction during Oxaliplatin-Based Chemotherapy for Colorectal Cancer: A Phase II Randomized Clinical Trial.

J Pain Symptom Manage 2019 Jun 26. Epub 2019 Jun 26.

Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2019.06.018DOI Listing
June 2019

Current synthetic pharmacotherapy for treatment-resistant colorectal cancer: when urgent action is required.

Expert Opin Pharmacother 2019 Apr 8;20(5):523-534. Epub 2019 Jan 8.

a Gastrointestinal Medical Oncology Department , The University of Texas M. D. Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2018.1561866DOI Listing
April 2019

The Management and Prevention of Anal Squamous Cell Carcinoma.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:216-225. Epub 2019 May 17.

3 East and North Hertfordshire NHS Trust, Lister Hospital, Stevenage, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_237433DOI Listing
January 2019

Minimally invasive management of the entire treatment sequence in patients with stage IV colorectal cancer: a propensity-score weighting analysis.

HPB (Oxford) 2018 Dec 11;20(12):1150-1156. Epub 2018 Jul 11.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hpb.2018.05.011DOI Listing
December 2018

Experimental and investigational drugs for the treatment of anal cancer.

Expert Opin Investig Drugs 2018 12 8;27(12):941-950. Epub 2018 Nov 8.

a Department of Gastrointestinal Medical Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/13543784.2018.1
Publisher Site
http://dx.doi.org/10.1080/13543784.2018.1543659DOI Listing
December 2018

Extended-Field Chemoradiation Therapy for Definitive Treatment of Anal Canal Squamous Cell Carcinoma Involving the Para-Aortic Lymph Nodes.

Int J Radiat Oncol Biol Phys 2018 09 5;102(1):102-108. Epub 2018 May 5.

Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2018.04.076DOI Listing
September 2018

The Long-Term Impact of Neurofeedback on Symptom Burden and Interference in Patients With Chronic Chemotherapy-Induced Neuropathy: Analysis of a Randomized Controlled Trial.

J Pain Symptom Manage 2018 05 5;55(5):1276-1285. Epub 2018 Feb 5.

Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2018.01.010DOI Listing
May 2018

Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort Study.

J Clin Oncol 2018 Feb 15:JCO2017756387. Epub 2018 Feb 15.

Jessica P. Hwang, Scott B. Cantor, Andrea Barbo, Heather Y. Lin, Jessica T. Foreman, Harrys A. Torres, Bruno P. Granwehr, Ethan Miller, Cathy Eng, George R. Simon, Sairah Ahmed, Alessandra Ferrajoli, Jorge Romaguera, and Maria E. Suarez-Almazor, The University of Texas MD Anderson Cancer Center; John M. Vierling, Baylor College of Medicine, Houston, TX; Anna S. Lok, University of Michigan, Ann Arbor, MI; and Michael J. Fisch, Aim Specialty Health, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.6387DOI Listing
February 2018

Role of Chemotherapy in the Neoadjuvant/Adjuvant Setting for Patients With Rectal Adenocarcinoma Undergoing Chemoradiotherapy and Surgery or Radiotherapy and Surgery.

Curr Oncol Rep 2018 01 23;20(1). Epub 2018 Jan 23.

Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 426, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-018-0652-7DOI Listing
January 2018

The promise of immunotherapy in anal squamous cell carcinoma: a novel approach for an orphan disease.

Clin Adv Hematol Oncol 2017 Dec;15(12):968-961

Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
December 2017

Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal.

Mol Cancer Res 2017 11 7;15(11):1542-1550. Epub 2017 Aug 7.

Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-17-0060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991496PMC
November 2017

Neoadjuvant Strategies: Locally Advanced Rectal Cancer.

Clin Colon Rectal Surg 2017 Nov 27;30(5):383-386. Epub 2017 Nov 27.

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0037-1606372
Publisher Site
http://dx.doi.org/10.1055/s-0037-1606372DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703667PMC
November 2017

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update.

J Clin Oncol 2017 Oct 31;35(28):3240-3261. Epub 2017 Jul 31.

Paul J. Hesketh, Lahey Hospital and Medical Center, Burlington; Kimberly Noonan, Dana-Farber Cancer Institute, Boston, MA; Mark G. Kris, Memorial Sloan Kettering Cancer Center, New York, NY; Ethan Basch and Stacie B. Dusetzina, University of North Carolina at Chapel Hill, Chapel Hill; Sally Y. Barbour, Duke University Medical Center, Durham, NC; Kari Bohlke and Mark R. Somerfield, American Society of Clinical Oncology, Alexandria; Michael A. Danso, Virginia Oncology Associates, Virginia Beach; Michael A. Danso, Virginia Oncology Associates, Norfolk, VA; Rebecca Anne Clark-Snow, University of Kansas Cancer Center, Westwood, KS; Cathy Eng, The University of Texas MD Anderson Cancer Center, Houston, TX; Dee Sparacio, Patient Representative, Hightstown, NJ; Gary H. Lyman, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; Kristopher Dennis, The Ottawa Hospital and University of Ottawa, Ottawa; L. Lee Dupuis, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada; Petra C. Feyer, Vivantes Clinics Neukoelln, Berlin; and Karin Jordan, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.4789DOI Listing
October 2017

Total Laparoscopic Management for Stage IV Colorectal Cancer Requiring Multivisceral Resection.

Ann Surg Oncol 2017 Sep 16;24(9):2595. Epub 2017 May 16.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-017-5878-3DOI Listing
September 2017

Pharmacotherapy of Anal Cancer.

Drugs 2017 Sep;77(14):1519-1530

Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-017-0792-3DOI Listing
September 2017

Randomized controlled trial of neurofeedback on chemotherapy-induced peripheral neuropathy: A pilot study.

Cancer 2017 06 3;123(11):1989-1997. Epub 2017 Mar 3.

Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30649DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470539PMC
June 2017

Total Transthoracic Approach Facilitates Laparoscopic Hepatic Resection in Patients with Significant Prior Abdominal Surgery.

Ann Surg Oncol 2017 May 22;24(5):1376-1377. Epub 2016 Nov 22.

Department of Surgical Oncology, Hepato-Pancreato-Biliary Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-016-5685-2DOI Listing
May 2017

Measurement of DNA damage in peripheral blood by the γ-H2AX assay as predictor of colorectal cancer risk.

DNA Repair (Amst) 2017 05 6;53:24-30. Epub 2017 Mar 6.

Departments of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15687864163041
Publisher Site
http://dx.doi.org/10.1016/j.dnarep.2017.03.001DOI Listing
May 2017

Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgery.

BMC Cancer 2017 05 15;17(1):331. Epub 2017 May 15.

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 0426, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://bmccancer.biomedcentral.com/articles/10.1186/s12885-0
Publisher Site
http://dx.doi.org/10.1186/s12885-017-3327-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433007PMC
May 2017

Definitive Chemoradiation for Squamous Cell Carcinoma of the Rectum.

Am J Clin Oncol 2017 Apr;40(2):163-166

Departments of *Radiation Oncology †Surgical Oncology ‡Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000126DOI Listing
April 2017

Low-grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP): Prognostic Factors and Implications for Treatment and Follow-up.

Ann Surg Oncol 2017 Jan 22;24(1):187-193. Epub 2016 Sep 22.

Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-016-5588-2DOI Listing
January 2017

Metastatic Anal Cancer and Novel Agents.

Surg Oncol Clin N Am 2017 01;26(1):133-142

Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 426, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soc.2016.07.008DOI Listing
January 2017

Preface.

Authors:
Cathy Eng

Surg Oncol Clin N Am 2017 01 25;26(1):xv-xvi. Epub 2016 Oct 25.

Colorectal Center, The University of Texas M.D. Anderson Cancer Center, Department of Gastrointestinal Medical Oncology, 1515 Holcombe Boulevard, Unit 426, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soc.2016.09.001DOI Listing
January 2017

Metastasis regulation by PPARD expression in cancer cells.

JCI Insight 2017 01 12;2(1):e91419. Epub 2017 Jan 12.

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/jci.insight.91419DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214933PMC
January 2017

POLE mutations in colorectal cancer: a new biomarker?

Authors:
Cathy Eng

Lancet Gastroenterol Hepatol 2016 11 20;1(3):176-177. Epub 2016 Jul 20.

Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(16)30030-9DOI Listing
November 2016

Summary of emerging targets in anal cancer: the case for an immunotherapy based-approach.

J Gastrointest Oncol 2016 Oct;7(5):721-726

UT MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jgo.2016.08.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056256PMC
October 2016

Epidermal growth factor receptor inhibition in metastatic anal cancer.

Anticancer Drugs 2016 09;27(8):804-8

aPharmacy Clinical Programs bDepartment of Gastrointestinal Medical Oncology, U.T. M.D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000383DOI Listing
September 2016

Prechemotherapy Touch Sensation Deficits Predict Oxaliplatin-Induced Neuropathy in Patients with Colorectal Cancer.

Oncology 2016 17;90(3):127-35. Epub 2016 Feb 17.

Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Tex., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000443377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794365PMC
July 2016

The Treatment of Colorectal Cancer During Pregnancy: Cytotoxic Chemotherapy and Targeted Therapy Challenges.

Oncologist 2016 05 21;21(5):563-70. Epub 2016 Mar 21.

Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0362DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861360PMC
May 2016

American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer Prevention.

J Clin Oncol 2016 05 11;34(15):1803-12. Epub 2016 Apr 11.

Howard H. Bailey, University of Wisconsin Carbone Cancer Center, Madison, WI; Linus T. Chuang, Mount Sinai School of Medicine, New York, NY; Nefertiti C. duPont, Gynecologic Surgeons of North Houston, Shenandoah; Cathy Eng and Lewis E. Foxhall, MD Anderson Cancer Center, Houston, TX; Janette K. Merrill and Dana S. Wollins, American Society of Clinical Oncology, Alexandria, VA; and Charles D. Blanke, Oregon Health and Science University, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.2014DOI Listing
May 2016

Perspectives on clinical trials for gastrointestinal malignancies.

Am Soc Clin Oncol Educ Book 2015 :40-3

From The University of Texas MD Anderson Cancer Center, Houston, TX; Stanford University School of Medicine, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2015.35.40DOI Listing
February 2016

Cetuximab in combination with cisplatin and 5-Fluorouracil induces dramatic response in metastatic refractory squamous cell carcinoma of the anal canal.

J Gastrointest Oncol 2015 Oct;6(5):E82-5

1 Pharmacy Clinical Programs, 2 Department of Gastrointestinal Medical Oncology, U.T. M.D. Anderson Cancer Center, Houston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2078-6891.2015.035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570906PMC
October 2015

Circulating DNA biomarkers: a primer for metastatic colorectal cancer?

Authors:
Cathy Eng

Lancet Oncol 2015 Aug 13;16(8):878-9. Epub 2015 Jul 13.

MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(15)00061-3DOI Listing
August 2015

Challenges of efficacy assessments in pseudomyxoma peritonea.

Oncologist 2015 Mar;20(3):e3-4

Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0415DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350806PMC
March 2015

Cetuximab in refractory squamous cell carcinoma of the anal canal.

J Gastrointest Cancer 2014 Dec;45 Suppl 1:198-200

Pharmacy Clinical Programs, U.T.M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12029-014-9626-7DOI Listing
December 2014

Intensity-modulated radiation therapy with concurrent chemotherapy for anal cancer: outcomes and toxicity.

Am J Clin Oncol 2014 Oct;37(5):461-6

Departments of *Radiation Oncology †Gastrointestinal Medical Oncology ‡Radiation Physics, UT MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e31827e52a3DOI Listing
October 2014

Optimal treatment strategies for anal cancer.

Curr Treat Options Oncol 2014 Sep;15(3):443-55

The Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 426, Houston, TX, 77030, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-014-0298-0DOI Listing
September 2014

Progression-free survival remains poor over sequential lines of systemic therapy in patients with BRAF-mutated colorectal cancer.

Clin Colorectal Cancer 2014 Sep 23;13(3):164-71. Epub 2014 Jun 23.

Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2014.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266576PMC
September 2014

Optimal management of squamous cell carcinoma of the anal canal: where are we now?

Expert Rev Anticancer Ther 2014 Aug 1;14(8):877-86. Epub 2014 Jul 1.

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 426, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2014.919861DOI Listing
August 2014

Preoperative chemotherapy prior to pulmonary metastasectomy in surgically resected primary colorectal carcinoma.

Oncotarget 2014 Aug;5(16):6584-93

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196147PMC
http://dx.doi.org/10.18632/oncotarget.2172DOI Listing
August 2014

Delayed Presentation of DPD Deficiency in Colorectal Cancer.

J Adv Pract Oncol 2014 May;5(3):205-10

University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114495PMC
May 2014

Atypical metastatic presentations in colorectal cancer: a case series.

Clin Colorectal Cancer 2014 Mar 12;13(1):e1-4. Epub 2013 Nov 12.

Department of Gastrointestinal Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2013.11.005DOI Listing
March 2014

Definitive chemoradiation in oligometastatic squamous cell carcinoma of the anal canal.

Gastrointest Cancer Res 2014 Mar;7(2):65-8

Department of Gastrointestinal Medical Oncology University of Texas M.D. Anderson Cancer Center Houston, TX.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007681PMC
March 2014

Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal.

Cancer 2013 Nov 20;119(21):3769-75. Epub 2013 Aug 20.

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28296DOI Listing
November 2013

Will PICCOLO affect metastatic colorectal cancer therapy?

Authors:
Cathy Eng

Lancet Oncol 2013 Jul 29;14(8):679-80. Epub 2013 May 29.

Department of GI Medical Oncology, Colorectal Center, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 426, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(13)70204-3DOI Listing
July 2013

Metformin use and improved response to therapy in rectal cancer.

Cancer Med 2013 Feb 3;2(1):99-107. Epub 2013 Feb 3.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas, 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.54DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797563PMC
February 2013

Identification of polymorphisms in ultraconserved elements associated with clinical outcomes in locally advanced colorectal adenocarcinoma.

Cancer 2012 Dec 6;118(24):6188-98. Epub 2012 Jun 6.

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27653DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465518PMC
December 2012

The promise of mTOR inhibitors in the treatment of colorectal cancer.

Expert Opin Investig Drugs 2012 Dec 16;21(12):1775-88. Epub 2012 Sep 16.

The University of Texas MD Anderson Cancer Center, Department of Gastrointestinal Medical Oncology, 1515 Holcombe, Unit 426, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/13543784.2012.72
Publisher Site
http://dx.doi.org/10.1517/13543784.2012.721353DOI Listing
December 2012

Genomic analysis and selected molecular pathways in rare cancers.

Phys Biol 2012 Dec 29;9(6):065004. Epub 2012 Nov 29.

Norris Comprehensive Cancer Center, Division of Medical Oncology, University of Southern California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1088/1478-3975/9/6/065004DOI Listing
December 2012

The current state of targeted agents in rectal cancer.

Int J Surg Oncol 2012 17;2012:406830. Epub 2012 May 17.

Department of Surgery, Catholic University of Daegu, 3056-6 Daemyung-4 Dong, Nam-Gu, Daegu 705-718, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/406830DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362864PMC
August 2012